$RMAX

RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS

RE/MAX Holdings (NYSE: RMAX) reported Q2 2026 revenue of $68.5M, down 5.8% year over year, and adjusted EBITDA of $22.9M, down 12.6%. GAAP net loss was $4.3M, or -$0.20 per diluted share. The company also disclosed a planned merger with The Real Brokerage, offering Real REMAX Group shares or $13.80 cash per RMAX share, expected to close in H2 2026.

Original reporting
Published Aug 6, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS — source image
Decision brief

The 30-second read

$RMAXBearishMed
01

Why it matters

The release combines weaker quarterly performance (revenue down, adjusted EBITDA down, GAAP net loss) with explicit guidance withdrawal during the merger process, increasing uncertainty around near-term earnings power until deal close in 2H 2026.

02

Market read

Traders get a fresh datapoint on Q2 profitability and revenue drivers, plus confirmation that RE/MAX will not provide quarterly guidance while the merger is pending.

03

What to watch

Transaction costs related to the merger increased operating expenses, and recurring revenue excluding marketing funds fell sharply, so traders should separate deal-related costs from underlying franchise demand.

Relevance 8/10Novelty 6/10Timing: after-hours earnings release today, ahead of Aug. 14 special meetings

Background

RE/MAX issued its Q2 2026 results and reiterated a pending acquisition by The Real Brokerage Inc. under an arrangement agreement announced April 26, 2026.

Company-level read

Ticker impact

$RMAXBearishMedium confidence
Context

RE/MAX reported Q2 2026 revenue of $68.5M, adjusted EBITDA of $22.9M, and a pending merger with Real Brokerage.

Expected impact

Bias to downside or volatility until deal milestones, shareholder approvals, and any deal-related updates.

Evidence & confidence

The release discloses a Q2 loss and declining revenue/EBITDA, and explicitly states no earnings call or quarterly/annual guidance while the merger is pending, which can reduce near-term visibility.

Market effects

Real-estate franchising and brokerage-tech peers may see read-across on fee-model changes (Aspire/Ascend) and agent-count trends.

U.S. and Canada agent-count declines highlighted, which can influence sentiment toward North American brokerage franchisors.

The merger framing targets a global technology-enabled platform, potentially affecting competitive positioning narratives in cross-border real estate services.

Counterpoint

The company’s agent count rose overall (+1.5%) and broker fees increased, which could indicate stabilization even as revenue and EBITDA declined.

Key entities

  • RE/MAX Holdings, Inc.

    Subject of the earnings release and the pending merger transaction.

  • The Real Brokerage Inc.

    Acquirer under the definitive arrangement agreement to create Real REMAX Group Inc.

  • Real REMAX Group Inc.

    Post-merger named platform entity referenced in the exchange/cash consideration terms.

Related articles

$RMAXMed

RE/MAX (NYSE:RMAX) Misses Q2 CY2026 Sales Expectations

RE/MAX (NYSE:RMAX) reported Q2 CY2026 results that missed Wall Street expectations. Revenue fell 5.8% year on year to $68.51 million, and non-GAAP adjusted EPS was $0.32, down from $0.39 and 18.6% below consensus. Analysts expect revenue to rise 3.3% and full-year EPS to increase from $1.15 to $1.33.

$RMAXMed

RE/MAX Holdings, Inc. (RMAX): Results of Operations and Financial Condition

RE/MAX Holdings, Inc. (RMAX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622438d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Total Second Quarter Revenue of $68.5 Million, Adjusted EBITDA of $22.9 Million DENVER, August 6, 2026 Second Quarter 2026 Highlights (Compared to second quarter 2

$RMAXMedAI 8/10

Why RE/MAX (RMAX) Stock Is Up Today

RE/MAX (RMAX) shares rose after the DOJ granted early termination of the HSR waiting period for its proposed merger with The Real Brokerage, removing a key antitrust review hurdle. The deal still requires shareholder approvals. RMAX closed at $10.71, up 0.9% on the day.

$RMAXMedAI 8/10

Real-REMAX Deal Clears DOJ and FTC Scrutiny

Real’s SEC filing says the DOJ granted early termination of the antitrust waiting period for Real’s $880 million bid to buy RE/MAX. The FTC says early termination occurs only after both agencies complete review and plan no enforcement during the period. Shareholder approval is set for Aug. 14. Real shares rose about 4% after the filing.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.